155 related articles for article (PubMed ID: 860726)
21. Evidence that an autoantibody of IgG3 subclass against C3b discloses a C3 Nef activity in a pateint with partial lipodystrophy and glomerulonephritis.
Fontaine M; Daveau M; Lebreton JP; Dumouchel L; Vannier JP; Godin M
Ann Immunol (Paris); 1980; 131C(1):39-53. PubMed ID: 6901590
[TBL] [Abstract][Full Text] [Related]
22. Membranoproliferative glomerulonephritis with partial lipodystrophy: discordant occurrence in identical twins.
Reichel W; Köbberling J; Fischbach H; Scheler F
Klin Wochenschr; 1976 Jan; 54(2):75-81. PubMed ID: 129586
[TBL] [Abstract][Full Text] [Related]
23. C3 nephritic factor and SLE: report of four cases and review of the literature.
Walport MJ; Davies KA; Botto M; Naughton MA; Isenberg DA; Biasi D; Powell RJ; Cheung NT; Struthers GR
QJM; 1994 Oct; 87(10):609-15. PubMed ID: 7987656
[TBL] [Abstract][Full Text] [Related]
24. [Mesangiocapillary glomerulonephritis and rheumatoid arthritis. A case with diagnostic and therapeutic questions (author's transl)].
Bürkle PA; Tönnesmann E; Franz HE; Federlin K
Immun Infekt; 1976 Apr; 4(2):79-83. PubMed ID: 61163
[TBL] [Abstract][Full Text] [Related]
25. [Complement and nephritic activity in membranoproliferative glomerulonephritis].
Lévy M; Sich M; Habib R
Arch Fr Pediatr; 1979 Nov; 36(9 Suppl):LXIV-LXXIV. PubMed ID: 539879
[TBL] [Abstract][Full Text] [Related]
26. Letter: Membranoproliferative nephritis and C3NeF.
Wardle EN
N Engl J Med; 1976 Aug; 295(6):343. PubMed ID: 934218
[No Abstract] [Full Text] [Related]
27. Familial incidence of C3 nephritic factor, partial lipodystrophy and membranoproliferative glomerulonephritis.
Power DA; Ng YC; Simpson JG
Q J Med; 1990 Apr; 75(276):387-98. PubMed ID: 2385743
[TBL] [Abstract][Full Text] [Related]
28. Partial lipodystrophy with nephrotic syndrome.
Hunter AM; Lawson AA; Thomson D
Postgrad Med J; 1978 Apr; 54(630):286-91. PubMed ID: 662798
[TBL] [Abstract][Full Text] [Related]
29. C3 nephritic factor and hypocomplementaemia in a clinically healthy individual.
Gewurz AT; Imherr SM; Strauss S; Gewurz H; Mold C
Clin Exp Immunol; 1983 Oct; 54(1):253-8. PubMed ID: 6616970
[TBL] [Abstract][Full Text] [Related]
30. Partial lipodystrophy and renal disease.
Lenane P; Murphy G
Clin Exp Dermatol; 2000 Nov; 25(8):605-7. PubMed ID: 11167971
[TBL] [Abstract][Full Text] [Related]
31. C3 nephritic factor and C4 nephritic factor in the serum of two patients with hypocomplementaemic membranoproliferative glomerulonephritis.
Tanuma Y; Ohi H; Watanabe S; Seki M; Hatano M
Clin Exp Immunol; 1989 Apr; 76(1):82-5. PubMed ID: 2736802
[TBL] [Abstract][Full Text] [Related]
32. Effect of nephritic factor on C3 and on the terminal pathway of complement in vivo and in vitro.
Mollnes TE; Ng YC; Peters DK; Lea T; Tschopp J; Harboe M
Clin Exp Immunol; 1986 Jul; 65(1):73-9. PubMed ID: 3641694
[TBL] [Abstract][Full Text] [Related]
33. [Partial lipodystrophy with osteomyelitis (author's transl)].
Böhles H; Kövary PM
Klin Padiatr; 1982 Mar; 194(2):124-7. PubMed ID: 7098372
[No Abstract] [Full Text] [Related]
34. [Studies of complement, nephritic factor, and circulating immune complexes in chronic mesangiocapillary glomerulonephritis types I and II (author's transl)].
Mirapeix E; Yagüe J; Vives J; Revert L
Med Clin (Barc); 1981 Jun; 77(1):21-6. PubMed ID: 7253758
[TBL] [Abstract][Full Text] [Related]
35. C3 nephritic factor (C3NeF): dissociation of cell-bound and fluid phase stabilization of alternative pathway C3 convertase.
Ng YC; Peters DK
Clin Exp Immunol; 1986 Aug; 65(2):450-7. PubMed ID: 3641695
[TBL] [Abstract][Full Text] [Related]
36. Metabolism of the fifth component of complement, and its relation to metabolism of the third component, in patients with complement activation.
Sissons JG; Liebowitch J; Amos N; Peters DK
J Clin Invest; 1977 Apr; 59(4):704-15. PubMed ID: 845257
[TBL] [Abstract][Full Text] [Related]
37. Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.
Perrin LH; Lambert PH; Miescher PA
J Clin Invest; 1975 Jul; 56(1):165-76. PubMed ID: 1141431
[TBL] [Abstract][Full Text] [Related]
38. Mesangiocapillary glomerulonephritis with dense "deposits" in the basement membranes of the kidney.
Vargas R; Thomson KJ; Wilson D; Cameron JS; Turner DR; Gill D; Chantler C; Ogg CS
Clin Nephrol; 1976 Feb; 5(2):73-82. PubMed ID: 767025
[TBL] [Abstract][Full Text] [Related]
39. C3 nephritic factor in an individual with recurrent viral infection and lipodystrophy.
Myers B; Chambers R; Anderson A; Barry R; Wallington T; Whicher J
J Clin Lab Immunol; 1986 Apr; 19(4):201-4. PubMed ID: 3723590
[TBL] [Abstract][Full Text] [Related]
40. Hereditary angio-oedema with mesangiocapillary glomerulonephritis.
Plaza J; Malasit P; Kerr DN
Postgrad Med J; 1977 Oct; 53(624):627-30. PubMed ID: 593984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
